This document is an excerpt from the EUR-Lex website
Document 62015TN0355
Case T-355/15: Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)
Case T-355/15: Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)
Case T-355/15: Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)
IO C 294, 7.9.2015, p. 79–80
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
7.9.2015 |
EN |
Official Journal of the European Union |
C 294/79 |
Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)
(Case T-355/15)
(2015/C 294/95)
Language in which the application was lodged: English
Parties
Applicant: Alpex Pharma SA (Mezzovico-Vira, Switzerland) (represented by: C. Bacchini and M. Mazzitelli, lawyers)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)
Other party to the proceedings before the Board of Appeal: Astex Pharmaceuticals, Inc. (Pleasanton, United States)
Details of the proceedings before OHIM
Applicant: The other party to the proceedings before the Board of Appeal
Trade mark at issue: Community word mark ‘ASTEX’ — Application for registration No 1 0 8 05 281
Procedure before OHIM: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of OHIM of 28 April 2015 in Case R 593/2014-2
Form of order sought
The applicant claims that the Court should:
— |
annul the contested decision; |
— |
order OHIM and the other party to the proceedings before the Board of Appeal, should it intervene, to pay the costs. |
Plea in law
— |
Infringement of Article 8(1)(b) of Regulation No 207/2009. |